Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (101-110 of 300) with videos related to

Pageof 30
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin LymphomaRachel J David, Andrea Baran, Kah Poh Loh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Journal of Geriatric Oncology|July 31, 2021
Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapyAnita J Kumar, Jason Nelson, Angie Mae Rodday, et al.
Cancer|September 6, 2013
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare StudyPeter Martin, Michelle Byrtek, Keith Dawson, et al.
Leukemia Research|October 26, 2005
Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experienceRoberto L Vargas, Enzo Fallone, Raymond E Felgar, et al.
British Journal of Haematology|February 25, 2020
First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based studyAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
JCO Oncology Advances|April 23, 2025
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low-Tumor Burden Follicular LymphomaNilanjan Ghosh, Shay Bellasea, Hongli Li, et al.
JAMA Network Open|October 21, 2021
Association of Treatment Intensity With Survival in Older Patients With Hodgkin LymphomaAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2023
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma PopulationKriti Thapa, Myla Strawderman, Patrick M Reagan, et al.
British Journal of Haematology|June 19, 2015
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cellsAndrew G Evans, Paul G Rothberg, W Richard Burack, et al.
Pageof 30

Showing results (101-110 of 300) with videos related to

Sort By:
Pageof 30
Clinical Lymphoma, Myeloma & Leukemia|September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin LymphomaRachel J David, Andrea Baran, Kah Poh Loh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Journal of Geriatric Oncology|July 31, 2021
Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapyAnita J Kumar, Jason Nelson, Angie Mae Rodday, et al.
Cancer|September 6, 2013
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare StudyPeter Martin, Michelle Byrtek, Keith Dawson, et al.
Leukemia Research|October 26, 2005
Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experienceRoberto L Vargas, Enzo Fallone, Raymond E Felgar, et al.
British Journal of Haematology|February 25, 2020
First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based studyAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
JCO Oncology Advances|April 23, 2025
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low-Tumor Burden Follicular LymphomaNilanjan Ghosh, Shay Bellasea, Hongli Li, et al.
JAMA Network Open|October 21, 2021
Association of Treatment Intensity With Survival in Older Patients With Hodgkin LymphomaAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2023
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma PopulationKriti Thapa, Myla Strawderman, Patrick M Reagan, et al.
British Journal of Haematology|June 19, 2015
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cellsAndrew G Evans, Paul G Rothberg, W Richard Burack, et al.
Pageof 30